Using genetically predicted metabolic reaction fluxes, the authors identify reactions that can amplify or buffer the effect ...

Secondary endpoints in the MINDFuL trial include the CDR-SB, E-Cog, ADL and Neuropsychiatric Inventory (NPI) instruments, along with blood biomarker and neuroimaging outcomes. Baseline demographics, ...

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, focuses here on CYP genes, haplotypes, and their ...

Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.

In the US, where Kisunla was approved last year, the Food and Drug Administration required a boxed warning on Kisunla's label, in which it recommends genetic testing to assess whether a patient ...

A recent study released by the University of Wisconsin-Madison sheds light on how the sugary enhancer1 (se1) allele influences the nutritional profile ...

Wave Life Sciences Ltd.’s WVE share price has dipped by 10.08%, which has investors questioning if this is right time to buy.

Maze Therapeutics IPOs at $487M, targeting APOL1 Kidney Disease with MZE829 in Phase 2. Click here to read an analysis of MAZE stock now.

The lipid transport protein called Apolipoprotein E provides an elevated risk to individuals for AMD if they carry the allele ...

A JAMA Network Open study finds that better cardiovascular health (CVH) in older adults is linked to lower levels of neurodegenerative biomarkers, particularly neurofilament light chain (NfL). These ...

Baritone Craig Irvin, left, as Thalasso, soprano Shayla Sauvie as Kosmo, soprano Angela Yam as Orsia and members of the San Francisco Girls Chorus in Opera Parallèle’s world-premiere production of ...